HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monika Vainorius Selected Research

Monika Vainorius Research Topics

Disease

9Fibrosis (Cirrhosis)
01/2020 - 02/2015
6Infections
12/2021 - 01/2016
3Chronic Hepatitis C
12/2021 - 02/2015
3Hepatitis C
12/2019 - 01/2017
2Liver Diseases (Liver Disease)
12/2021 - 02/2015
1Hepatitis
12/2021
1End Stage Liver Disease
01/2020
1Hepatocellular Carcinoma (Hepatoma)
10/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2017

Drug/Important Bio-Agent (IBA)

6AlbuminsIBA
01/2020 - 02/2015
5Antiviral Agents (Antivirals)IBA
12/2021 - 01/2017
5Ribavirin (Virazole)FDA LinkGeneric
12/2019 - 01/2016
5SofosbuvirIBA
12/2019 - 01/2016
4BilirubinIBA
01/2020 - 12/2016
2sofosbuvir drug combination ledipasvirIBA
12/2021 - 12/2016
2ledipasvirIBA
11/2018 - 12/2016
1L 644711 (B-3(+))IBA
12/2019
1glecaprevir and pibrentasvirIBA
12/2019
1Serum AlbuminIBA
10/2017
1Proton Pump InhibitorsIBA
12/2016
1RNA (Ribonucleic Acid)IBA
12/2016
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
02/2015
1telaprevirIBA
02/2015
1CreatinineIBA
02/2015

Therapy/Procedure

6Therapeutics
01/2020 - 02/2015
2Aftercare (After-Treatment)
12/2019 - 12/2016
2Liver Transplantation
10/2019 - 10/2017